Howmedica to license bone cement from Orthovita:
This article was originally published in Clinica
Executive Summary
Howmedica is to license Orthovita's new bone cement technology in an exclusive worldwide agreement. The Rutherford, New Jersey-based company will work with Orthovita to complete the development of Orthocomp, which received a US patent in 1997. Orthovita, located in Malvern, Pennsylvania, is expected to submit a 510(k) for non-load bearing applications. It plans to submit an Investigational Device Exemption (IDE) for load-bearing indications and as an implant cement by the end of the year. Of the annual 650,000 worldwide joint replacement procedures, about 60% involve the use of bone cement.